More than half of all venture capital dollars invested in small businesses and startups during the first three months of 2018 went straight into the state of California, according to a recent investment report from PwC and CB Insights suggesting the vast majority of business investment in the U.S. is concentrated in only a few states.
You’ve heard the cliché about wearing your heart on your sleeve. But a group of Army doctors did one better: They grew a new ear on a soldier’s forearm, using cartilage harvested from her ribs.
It pays to be a business in Baltimore. That’s the message that Johns Hopkins wants proprietors and their patrons to know as part of the institution’s HopkinsLocal initiative to support and invest in local enterprises.
Famous local inventor Robert E. Fischell is gifting $20 million to the University of Maryland School of Medicine in support of biomedical research.
The gift will be used to establish the Robert E. Fischell Center for Biomedical Innovation at the medical school, and provide funding for a planned new 450,000 square foot research building on the school’s Baltimore campus. It will also support research funds and endowed professorships for the new Fischell Center.
Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry.
The Emmes Corporation today announced that scientists and health professionals from the company, LDS Hospital in Salt Lake City, Utah, Lovelace Biomedical Environmental Research Institute in Albuquerque, New Mexico, and the U.S. Army Medical and Materiel Development Activity at Fort Detrick, Maryland, have completed a multi-year clinical trial testing hyperbaric oxygen as an intervention for U.S. military service members who have suffered mild traumatic brain injuries with persistent symptoms.
The first-quarter numbers for Emergent BioSolutions (NYSE:EBS) didn’t look too great. In fact, they were arguably ugly.
Rockville-based BeneVir Biopharm Inc., a biotech specializing in immunotherapy treatments for cancer, has reached a deal to sell to pharmaceutical goliath Janssen Biotech Inc., a Johnson & Johnson company, in a deal worth up to $1.04 billion.
Think of The Collective as a 15K SF clubhouse for big kids. Grownups are welcome, but leave your electronic devices in your pockets, please. This is about face-to-face fun.
1,129,744 patient records were breached between January and March 2018, according to new data released today in the Protenus Breach Barometer. Published by Protenus, an artificial intelligence platform used by top health systems to analyze every access to patient data inside the electronic health record (EHR), the Breach Barometer is the industry’s definitive source for health data breach reporting.
